Granting Petitions To Add 1-bromopropane (Also Known as 1-BP) to the List of Hazardous Air Pollutants, 36851-36855 [2020-13145]

Download as PDF Federal Register / Vol. 85, No. 118 / Thursday, June 18, 2020 / Notices burden compared with the ICR currently approved by OMB. Dated: June 12, 2020. David R. Lloyd, Director, Office of Brownfields and Land Revitalization. Dated: June 12, 2020. Mary Ross, Director, Office of Science Advisor, Policy, and Engagement. [FR Doc. 2020–13169 Filed 6–17–20; 8:45 am] BILLING CODE 6560–50–P [FR Doc. 2020–13168 Filed 6–17–20; 8:45 am] BILLING CODE 6560–50–P ENVIRONMENTAL PROTECTION AGENCY ENVIRONMENTAL PROTECTION AGENCY [EPA–HQ–OAR–2014–0471; FRL–10010–36– OAR] RIN 2060–AS26 [EPA–HQ–ORD–2015–0635; FRL 10011–01– ORD] Board of Scientific Counselors (BOSC) Chemical Safety for Sustainability and Health and Environmental Risk Assessment Subcommittee Meeting— June 2020; Correction Granting Petitions To Add 1bromopropane (Also Known as 1–BP) to the List of Hazardous Air Pollutants Environmental Protection Agency (EPA). ACTION: Notice. AGENCY: The U.S. Environmental Protection Agency (EPA) is granting petitions to add n-propyl bromide (nPB) (Chemical Abstract Service (CAS) No. 106–94–5) to the list of hazardous air pollutants (HAP) contained in the Clean Air Act (CAA). The EPA is taking final action to grant these petitions based on the petitioners having met the requirements contained in CAA section 112(b)(3), which allows any person to petition the Administrator to add a substance to the list of HAP. The term 1-bromopropane (1–BP), which is used throughout this document, is the common name for nPB. This is the first occasion on which the EPA is granting petitions to add a substance to the list of HAP that Congress created in 1990. Following this action, the EPA will take a separate regulatory action to add 1–BP to the list of HAP under CAA section 112(b)(1). DATES: The petitions are granted as of June 18, 2020. ADDRESSES: The EPA has established a docket for this document under Docket ID No. EPA–HQ–OAR–2014–0471. All documents in the docket are listed on the https://www.regulations.gov/ website. Although listed, some information is not publicly available, e.g., Confidential Business Information or other information whose disclosure is restricted by statute. Certain other material, such as copyrighted material, is not placed on the internet and will be publicly available only in hard copy form. Publicly available docket materials are available electronically through https://www.regulations.gov/. Out of an abundance of caution for members of the public and our staff, the EPA Docket Center and Reading Room was closed to public visitors on March 31, 2020, to reduce the risk of SUMMARY: Environmental Protection Agency (EPA). AGENCY: Notice of public meeting; correction. ACTION: The Environmental Protection Agency (EPA), Office of Research and Development (ORD), published a document in the Federal Register of June 2, 2020, giving notice of a meeting of the Board of Scientific Counselors (BOSC) Chemical Safety for Sustainability and Health and Environmental Risk Assessment (CSS– HERA) Subcommittee. The meeting has been postponed until June 24, 2020. Due to unforeseen administrative circumstances, EPA is announcing this meeting with less than 15 calendar days’ notice. SUMMARY: The Designated Federal Officer (DFO) via phone/voice mail at: (202) 564–6518 or via email at: tracy.tom@epa.gov. FOR FURTHER INFORMATION CONTACT: SUPPLEMENTARY INFORMATION: Correction In the Federal Register of June 2, 2020, in FR Doc. 2020–11816, on page 33,665, column 1 correct the ‘‘DATES’’ caption to read: The videoconference meeting will be held on Wednesday, June 24, 2020, from 3:00 p.m. to 6:00 p.m. (EDT). Meeting times are subject to change. This meeting is open to the public. Those who wish to attend must register by June 23, 2020. Comments must be received by June 22, 2020 to be considered by the subcommittee. Requests for the draft agenda or making a presentation at the meeting will be accepted until June 22, 2020. DATES: VerDate Sep<11>2014 17:40 Jun 17, 2020 Jkt 250001 PO 00000 Frm 00024 Fmt 4703 Sfmt 4703 36851 transmitting COVID–19. Our Docket Center staff will continue to provide remote customer service via email, phone, and webform. There is a temporary suspension of mail delivery to the EPA, and no hand deliveries are currently accepted. For further information and updates on EPA Docket Center services and the current status, please visit us online at https:// www.epa.gov/dockets. FOR FURTHER INFORMATION CONTACT: For questions about this final action, contact Mr. John Schaefer, Sector Policies and Programs Division, Policies and Strategies Group (D205–02), Office of Air Quality Planning and Standards, Environmental Protection Agency, Research Triangle Park, North Carolina 27711; telephone number: (919) 541– 0296; fax number: (919)–541–4991; and email address: schaefer.john@epa.gov. SUPPLEMENTARY INFORMATION: Acronyms and abbreviations. We use multiple acronyms and terms in this document. While this list may not be exhaustive, to ease the reading of this document and for reference purposes, the EPA defines the following terms and acronyms here: 1–BP 1-bromopropane (also known as npropyl bromide (nPB)) CAA Clean Air Act CAS Chemical Abstract Service EPA Environmental Protection Agency HAP hazardous air pollutant(s) HSIA Halogenated Solvents Industry Alliance ICL Israel Chemicals Ltd. MOA mode of action NESHAP national emission standards for hazardous air pollutants NTP National Toxicology Program NYSDEC New York State Department of Environmental Conservation OMB Office of Management and Budget PERC perchloroethylene TRI Toxics Release Inventory Organization of this document. The information in this document is organized as follows: I. Background A. How do I obtain a copy of this document and other related information? B. CAA Authority: Petitions to Modify the List of HAP C. Petitions Submitted to the EPA II. What comments were received on the draft document to grant the petitions to add 1– BP to the CAA section 112(b)(1) HAP list? A. Comments Regarding Estimated 1–BP Emissions B. Comments on 1–BP Cancer Risk Factors C. Comments Requesting the Addition of 1–BP to the CAA Section 112(b)(1) HAP List III. The EPA’s Decision to Grant the Petitions IV. Reducing Emissions from Sources of 1– BP V. Statutory and Executive Order Review E:\FR\FM\18JNN1.SGM 18JNN1 36852 Federal Register / Vol. 85, No. 118 / Thursday, June 18, 2020 / Notices A. Executive Order 12866: Regulatory Planning and Review and Executive Order 13563: Improving Regulation and Regulatory Review I. Background A. How do I obtain a copy of this document and other related information? The docket number for this final action is Docket ID No. EPA–HQ–OAR– 2014–0471. In addition to being available in the docket, an electronic copy of this document will also be available on the internet. The EPA will post a copy of this final action at https:// www3.epa.gov/ttn/atw/pollutants/ atwsmod.html following official Agency signature. Following publication in the Federal Register, the EPA will post the Federal Register version and key technical documents on this same website. B. CAA Authority: Petitions To Modify the List of HAP The CAA section 112(b)(3)(A) specifies that any person may petition the Administrator to modify the list of HAP contained in CAA section 112(b)(1) by adding or deleting a substance. CAA section 112(b)(3)(B) sets out the substantive criteria for granting a petition. It calls for the Administrator to add a substance to the CAA section 112(b)(1) list, otherwise known as the HAP list, ‘‘upon a showing by the petitioner or on the Administrator’s own determination that the substance is an air pollutant and that emissions, ambient concentrations, bioaccumulation or deposition of the substance are known to cause or may reasonably be anticipated to cause adverse effects to human health or adverse environmental effects.’’ The Administrator is required under the CAA section 112(b)(3)(A) to either grant or deny a petition within 18 months of the receipt of a complete petition by publishing a written explanation of the reasons for the Administrator’s decision. The Administrator may not deny a petition based solely on inadequate resources or time for review. Finally, under the CAA section 112(e)(4), the Administrator’s decision to add a pollutant to the CAA section 112(b)(1) HAP list is not a final Agency action subject to judicial review, except that any such action may be reviewed when the Administrator promulgates emission standards for the pollutant. Accordingly, this decision to grant petitions to add 1–BP to the HAP list is not subject to judicial review until the Administrator promulgates applicable the CAA section 112(d) standards addressing emissions of 1–BP. Under VerDate Sep<11>2014 17:40 Jun 17, 2020 Jkt 250001 the CAA section 112(d) the EPA has a ‘‘clear statutory obligation to set emissions standards for each listed HAP.’’ National Lime Association v. EPA, 233 F. 3d 625, 634 (D.C. Cir. 2000). Additionally, under CAA section 112(c)(5), the EPA is required to promulgate emission standards under the CAA sections 112(d)(2) and (3) within two years of adding a new source category to the CAA section 112(c)(1) source category list. This is the first occasion on which the EPA is granting a petition to add a substance to the list of HAP that Congress created in 1990. Since 1990, the EPA has amended the CAA section 112(b)(1) HAP list by removing four listed HAPs. They are caprolactam (61 FR 30816 (June 18, 1996)); ethylene glycol monobutyl ether (69 FR 69320 (August 2, 2000)); surfactant alcohol ethoxylates and their derivatives (these are compounds that were considered to be included in glycol ethers, which is a listed HAP; (65 FR 47342 (August 2, 2000)); and methyl ethyl ketone (MEK) (70 FR 75047 (December 19, 2005)). For more information, see https:// www.epa.gov/haps/initial-listhazardous-air-pollutantsmodifications#mods. The EPA has also denied a petition to remove methanol from the CAA section 112(b)(1) HAP list. 66 FR 21929 (May 2, 2001). C. Petitions Submitted to the EPA Halogenated Solvents Industry Alliance (HSIA) and New York State Department of Environmental Conservation (NYSDEC) submitted petitions to add 1–BP to the CAA section 112(b)(1) HAP list on October 28, 2010, and November 24, 2011, respectively. Both HSIA and NYSDEC petitions referred to the chemical as nPB and 1–BP. In an action published on November 23, 2015, the EPA added the chemical by the name 1–BP to the Community Right-to-Know Toxic Chemical Release Reporting requirements. In addition, the chemical is listed in the EPA’s Substance Registry Services, the EPA’s authoritative resource for basic information about chemicals, as 1–BP. Finally, the chemical is currently undergoing an EPA Toxic Substances Control Act risk evaluation, under Docket ID No. EPA– HQ–OPPT–2015–0084 as 1–BP. Therefore, for this action and for future regulations under the CAA, the EPA will refer to the chemical identified by CAS No. 106–94–5 as 1-bromopropane or 1–BP. On November 28, 2012, in response to the EPA’s requests for additional data, HSIA supplemented its petition. Following the receipt of the petitions, PO 00000 Frm 00025 Fmt 4703 Sfmt 4703 the EPA conducted a review to determine whether the petitions were complete according to Agency criteria for the CAA section 112(b) actions, which we explained in the February 6, 2015, document (80 FR 6676). Specifically, after reviewing these petitions and supplemental information, the EPA determined that the petitions addressed all the necessary subject areas for the Agency to assess whether emissions, ambient concentrations, bioaccumulation, or deposition of 1–BP are known to cause or may reasonably be anticipated to cause adverse human health effects or adverse environmental effects. The EPA determined these petitions to add 1–BP to the HAP list to be complete and published a notification of receipt of a complete petition in the Federal Register on February 6, 2015 (80 FR 6676), and invited the public to comment on the technical merits of these petitions and to submit any information relevant to the technical review of the petitions. On March 11, 2015 (80 FR 12794), the EPA agreed to extend the comment period for the notification of receipt of complete petitions to May 7, 2015. On January 9, 2017, the EPA published a draft document in the Federal Register containing the Agency’s intended rationale for granting the petitions to add 1–BP to the CAA section 112(b)(1) HAP list (82 FR 2354). In the draft document, the EPA determined that these petitions met criteria specified in the CAA section 112(b): i.e., 1–BP is an air pollutant and its emissions and ambient concentrations ‘‘may reasonably be anticipated to cause adverse effects to human health.’’ Subsequently, on June 6, 2017, the EPA published an action granting the request by Albemarle Corporation, a U.S.-based manufacturer of 1–BP, to extend the comment period until October 1, 2017, to provide an opportunity for prospective commenters to review the 2017 Toxics Release Inventory (TRI), which included newly required emission reporting of 1–BP (82 FR 26091). This current action is the final step in granting the petitioners’ request to add 1–BP to the CAA section 112(b)(1) HAP list. Even following the granting of this petition to add 1–BP to the list, sources will remain under no regulatory or statutory obligation to reduce emissions of 1–BP until a separate regulatory action is taken. In section IV of this document, we explain the future additional regulatory actions that the EPA intends to consider either simultaneously with the addition of 1– BP to the CAA section 112(b)(1) HAP list or soon thereafter. E:\FR\FM\18JNN1.SGM 18JNN1 Federal Register / Vol. 85, No. 118 / Thursday, June 18, 2020 / Notices II. What comments were received on the draft document to grant the petitions to add 1–BP to the CAA section 112(b)(1) HAP list? The EPA received 12 comments on the draft document to add 1–BP to the CAA section 112(b)(1) list of HAP. Two commenters opposed adding 1–BP to the CAA section 112(b)(1) HAP list, while 10 commenters supported the action. All comments are in the docket for this action. A summary of the major comments and our responses are presented in this section. A. Comments Regarding Estimated 1–BP Emissions Comment: Albemarle Corporation requested that the EPA extend the comment period to October 1, 2017, to ensure that data from the TRI database for 1–BP would inform the final document. Albemarle Corporation stated the extension would provide the public with an opportunity to review the TRI dataset for 1–BP usage, sources, and emissions and also to use those data to prepare meaningful comments on the draft document. Response: The EPA also agreed that it would be useful to review reported TRI emissions releases for 1–BP prior to finalizing the document. Since January 2017, when the draft document was published, two years of emissions data had been submitted to the EPA’s TRI. Specifically, one commenter provided TRI data for 1–BP for calendar year 2016 during the extended comment period. Further, according to the EPA’s TRI, in 2016, 55 facilities (in 27 states) reported emissions totaling 626,659 pounds (more than 313 tons) of 1–BP into the air, with multiple sources reporting emissions in excess of 20,000 pounds (10 tons per year). Total 1–BP air emissions reported to TRI in 2017 were 746,562 pounds (more than 373 tons). Finally, the emissions data provided supported the risk analysis submitted by HSIA. The primary risk driver for the analysis was a degreasing operation in Collegeville, Pennsylvania, where the maximum individual lifetime risk was estimated at 38-in-1 million. The emissions reported by the facility to the TRI database showed approximately 70 tons per year of 1–BP emissions, which supports the petitioner’s emissions estimates and the assertion that 1–BP may present a risk to human health. Comment: Albemarle Corporation also commented that the emission estimates used by petitioners to estimate the fenceline ambient concentration of 1–BP lacked accuracy and were ‘‘wholly inadequate to support the petition.’’ They requested an extension of the VerDate Sep<11>2014 17:40 Jun 17, 2020 Jkt 250001 comment period to October 1, 2017, in order to resolve the significant differences between the estimates provided by the petitioner, HSIA, and the commenter’s estimated emissions. Response: The EPA agreed that resolving any differences between the commenter’s emission estimates and the petitioner’s estimates was an important issue that needed to be resolved prior to deciding on the petitions. Therefore, the EPA extended the comment period until October 1, 2017 (82 FR 26091, June 6, 2017). The commenter, however, did not provide additional information during the comment period extension. The EPA evaluated HSIA’s emission estimates and modeling assumptions and found them to be reasonable and found their risk assessment methodology consistent with the best practices for estimating carcinogenic risk for an air pathway analysis. Given that no evidence was provided to change the EPA’s previous review of the petitioner’s risk assessment, the petitioner’s original emission estimates used for the air pathway risk modeling were found to be acceptable and to provide the basis for a reasonable analysis of the risks associated with inhalation of 1–BP. B. Comments on 1–BP Cancer Risk Factors Comment: Israel Chemicals Ltd. (ICL) requested that the EPA reconsider its initial decision to add 1–BP to the HAP list. ICL made this request based on a September 2016 study titled In Vivo Mutation Assay of n-Propyl Bromide at the cII Locus in Big Blue® Transgenic B6C3F1 Mice Exposed via Whole-Body Inhalation.1 Based on this study, ICL argued for removing cancer as a potential hazard from 1–BP exposure, which, in their view, would eliminate the basis for listing 1–BP as a HAP. Response: The EPA rejects the premise that the results of a single assay for mutagenicity in a single gene locus in a transgenic (Big Blue®) mouse strain can be used to make general statements on potential mutagenicity or carcinogenicity. The EPA finds adequate support from submitted evidence and comments that 1–BP presents a potential cancer hazard and, therefore, is granting these petitions to list 1–BP as a HAP for purposes of regulatory actions based on the following considerations: First, not all carcinogens operate via a mutagenic mode of action (MOA). In fact, many of the National Toxicology Program (NTP) substances categorized 1 https://www.regulations.gov/, Docket ID Item No. EPA–HQ–OAR–2014–0471–0067. PO 00000 Frm 00026 Fmt 4703 Sfmt 4703 36853 as ‘‘Known to be a human carcinogen’’ are carcinogenic via non-mutagenic mechanisms. There is mixed evidence of mutations in bacterial and mammalian cells and limited data on DNA damage in 1–BP-exposed workers. However, there is clear evidence for the carcinogenicity of 1–BP in multiple tissues in two rodent species from a 2year cancer bioassay 2 by the NTP. The NTP’s Report on Carcinogens, 14th Edition 3 finds 1–BP is ‘‘reasonably anticipated to be a human carcinogen’’ based on sufficient evidence of carcinogenicity from studies in experimental animals. Second, regarding the ICL claim that if 1–BP is not a mutagen, any cancer potential will be a threshold effect. The 2005 EPA Cancer Guidelines 4 provide the latitude to apply a non-linear model when data positively establish the MOA to be non-linear. However, it is not automatically assumed that a non-linear MOA is operational if a chemical is not a mutagen. Third, as explained in greater detail in the draft document, there is significant evidence that 1–BP poses a negative health impact for noncancer effects including reproductive toxicity and neurotoxicity in both controlled and uncontrolled environments; the evidence for these noncancer effects provides sufficient justification to list 1– BP as a HAP, regardless of the potential for a cancer effect (82 FR 2354, 2360– 61, January 9, 2017). Finally, as also explained in the draft document, the EPA ‘‘interpret[s] the CAA section 112(b)(3)(B) as invoking the Administrator’s expertise in considering information/data that addresses the potential or likelihood of harm rather than concrete proof of actual harm,’’ and that the Administrator is authorized to ‘‘act in the face of uncertainty as to the proven health effects of a substance’’ and to ‘‘draw inferences from the data’’ before him. (82 FR 2357, January 9, 2017); see generally Id. at 2356–58, 2361–62. C. Comments Requesting the Addition of 1–BP to the CAA Section 112(b)(1) HAP List Comment: Ten commenters supported the EPA’s initial decision to grant petitions to add 1–BP to the CAA section 112(b)(1) HAP list and encouraged the EPA to issue a final action granting the petitions. They also 2 https://ntp.niehs.nih.gov/testing/status/agents/ ts-m000017.html. 3 https://ntp.niehs.nih.gov/ntp/roc/content/ profiles/bromopropane.pdf. 4 https://www.epa.gov/sites/production/files/ 2013-09/documents/cancer_guidelines_final_3-2505.pdf. E:\FR\FM\18JNN1.SGM 18JNN1 36854 Federal Register / Vol. 85, No. 118 / Thursday, June 18, 2020 / Notices stated that petitioners had provided substantial evidence to support the conclusion that 1–BP either is known to cause or can reasonably be anticipated to cause cancer and noncancer health effects in humans. Their comments generally discussed this evidence. One commenter stated that the decision to list 1–BP as a HAP under the CAA depends only on showing potential adverse effects from a chemical, not whether exposure is at levels that cause those effects. The commenter also noted that exposures of concern for 1–BP are already occurring. The commenter likewise disagreed with the negative mutagenesis assay findings submitted by ICL, stating that results of a single assay for mutagenicity cannot be used to apply across-the-board statements on potential mutagenicity. Response: The EPA acknowledges commenters’ statements. The EPA also agrees with the comments on the availability of substantial evidence to support the addition of 1–BP to the CAA section 112(b)(1) HAP list. III. The EPA’s Decision To Grant the Petitions Consistent with the draft document, petitioners have provided sufficient information demonstrating the adverse health effects of 1–BP that supports the EPA’s determination that 1–BP is an air pollutant as defined under the CAA section 302(g) and that ‘‘emissions, ambient concentrations, bioaccumulation or deposition of the substance are known to cause or may reasonably be anticipated to cause adverse effects to human health or adverse environmental effects’’ as specified under CAA section 112(b)(3)(B). The documented known or anticipated adverse health effects of 1– BP, which are based on established sound scientific principles, include carcinogenicity, reproductive toxicity, and neurotoxicity. The EPA also concludes that petitioners’ assessments regarding estimates of potential ambient concentrations of 1–BP that are likely to result at a facility’s fenceline, process emissions related information, and chemical usage information that are representative of normal operating conditions are reasonable. The EPA is, therefore, granting petitions to add 1–BP to the CAA section 112(b)(1) list of HAP. This action concludes the petition process under the CAA section 112(b)(3). As previously explained, the EPA’s granting of the petitions by itself, as accomplished by this document, does not impose any regulatory or statutory obligations on sources of 1–BP emissions. Following this action, the EPA will take a separate regulatory VerDate Sep<11>2014 17:40 Jun 17, 2020 Jkt 250001 action to add 1–BP to the list of HAP under the CAA section 112(b)(1). At that time, the EPA will publish a Federal Register document that formally proposes the addition of 1–BP to the CAA section 112(b)(1) HAP list and assess the impacts of adding 1–BP to the HAP list on potentially affected sources. IV. Reducing Emissions From Sources of 1–BP The first step in this process is to grant the petitions requesting that 1–BP be listed as a HAP, which we are completing with this action. As a general matter, granting a petition to add an air pollutant to the CAA section 112(b)(1) HAP list initiates the process of bringing the air pollutant into consideration in the national emission standards for hazardous air pollutants (NESHAP) program, under the CAA section 112(d). (The CAA section 112(d) imposes a ‘‘clear statutory obligation to set emissions standards for each listed HAP.’’ National Lime Association v. EPA, 233 F. 3d 625, 634 (D.C. Cir. 2000)). As previously explained, by itself, granting the petitions will not create new regulatory or statutory obligations for sources that emit 1–BP, until further actions are taken by the Agency. During the period from when this document is published and until the next step of adding 1–BP to the CAA section 112(b)(1) HAP list is taken, sources emitting 1–BP will have no regulatory obligations related to approval of the petitions. The second step is to publish a Federal Register document that formally announces the addition of 1– BP to the CAA section 112(b)(1) HAP list. In granting the petitions to list 1– BP as a HAP, the EPA has learned that most source categories emitting 1–BP will not become subject to emission standards until the EPA amends or promulgates new maximum achievable control technology standards for specific source categories. The single largest user of 1–BP is the Halogenated Solvent Cleaning source category. However, the current Halogenated Solvent Cleaning NESHAP (40 CFR part 63, subpart T) does not regulate 1–BP emissions because only emissions of methylene chloride, perchloroethylene (PERC), and trichloroethylene (TCE) are subject to the rule. Therefore, the use of 1–BP as a solvent degreaser will not be subject to regulation until such time as the EPA revises 40 CFR part 63, subpart T, issues new standards, or takes other actions to reduce 1–BP emissions from the Halogenated Solvent Cleaning source category. Further, the EPA may need to take additional regulatory action to address PO 00000 Frm 00027 Fmt 4703 Sfmt 4703 1–BP emissions from certain dry cleaning operations. The PERC Dry Cleaning source category, which sets out requirements for these operations, covers only PERC emissions. PERC is a solvent used in dry cleaning and has been identified as a probable human carcinogen. 40 CFR 63.322(o)(5)(i) requires that the existing co-residential dry cleaning subcategory phase out the use of PERC by December 21, 2020. The EPA has learned that 1–BP is currently used as a replacement solvent in this subcategory. Considering the public health effects discussed earlier in this document and the information before us, the EPA is concerned about the use of 1–BP as a substitute for PERC in the co-residential dry cleaning subcategory. Further, these public health effects may call for the need for adequate controls for 1–BP emissions from other dry cleaning subcategories other than the dry cleaning co-residential subcategory. The EPA is, therefore, planning in a future action to modify the CAA section 112(c)(1) source category list to add a new source category that would cover 1–BP emissions from all dry cleaning operations. Under the CAA section 112(c)(5), the EPA may add additional source categories to the CAA section 112(c)(1) source category list. Beyond the Halogenated Solvent Cleaning source category and 1–BP dry cleaning operations, the EPA does not believe that other source categories need to be added to the source category list or otherwise modified to reduce emissions of 1–BP. After adding a new source category to regulate 1–BP emissions from dry cleaning operations, the EPA would be required under CAA section 112(c)(5), to promulgate emission standards under the CAA section 112(d) within two years. Additionally, some sources could become immediately subject to existing standards once 1–BP is placed on the CAA section 112(b)(1) list given that these sources may become major sources of HAP emissions (greater than 10 tons per year of a single HAP or 25 tons per year of total HAP). For these sources, 40 CFR 63.6(c)(5) allows three years to comply after 1–BP is added to the HAP list unless the underlying rule specifies another schedule. These future actions that the EPA intends to consider for purposes of addressing 1–BP emissions reduction, such as the listing of new source categories under the CAA section 112(c)(1), can occur either simultaneously with listing 1–BP on the HAP list or shortly thereafter. In sum, as a result of granting these petitions, the EPA intends to consider taking additional regulatory actions as a result E:\FR\FM\18JNN1.SGM 18JNN1 Federal Register / Vol. 85, No. 118 / Thursday, June 18, 2020 / Notices of adding 1–BP to the CAA section 112(b)(1) HAP list. V. Statutory and Executive Order Review Additional information about this Executive Order can be found at https:// www.epa.gov/laws-regulations/lawsand-executive-orders. A. Executive Order 12866: Regulatory Planning and Review and Executive Order 13563: Improving Regulation and Regulatory Review This action is a significant regulatory action that was submitted to the Office of Management and Budget (OMB) for review because it raises novel legal or policy issues. Any changes made in response to OMB recommendations have been documented in the docket. Andrew Wheeler, Administrator. [FR Doc. 2020–13145 Filed 6–17–20; 8:45 am] BILLING CODE 6560–50–P FARM CREDIT SYSTEM INSURANCE CORPORATION Regular Meeting; Farm Credit System Insurance Corporation Board Farm Credit System Insurance Corporation. ACTION: Notice, regular meeting. AGENCY: Notice is hereby given, in accordance with the provisions of Article VI of the Bylaws of the Farm Credit System Insurance Corporation (FCSIC), that a regular meeting of the Board of Directors of FCSIC will be held June 25, 2020, at 10 a.m. EDT, until such time as the Board may conclude its business. Note: Because of the COVID– 19 pandemic, we will conduct the board meeting virtually. If you would like to observe the open portion of the virtual meeting, see instructions below for board meeting visitors. Attendance: To observe the open portion of the virtual meeting, go to FCSIC.gov, select ‘‘News & Events,’’ then ‘‘Board Meetings.’’ There you will find a description of the meeting and ‘‘Instructions for board meeting visitors.’’ See SUPPLEMENTARY SUMMARY: INFORMATION for further information about attendance requests. FOR FURTHER INFORMATION CONTACT: Dale Aultman, Secretary to the Board of the Farm Credit System Insurance Corporation (703) 883–4009. TTY is (703) 883–4056. SUPPLEMENTARY INFORMATION: Parts of this meeting of the Board will be open to the public, and parts will be closed. If you wish to observe the open portion, follow the instructions above in the ‘‘Attendance’’ section at least 24 hours before the meeting. Please note that this meeting begins at 10:00 a.m. EDT with a session that is closed to the public. You may join this meeting at 11:15 a.m. EDT. We will begin the open session promptly at 11:30 a.m. EDT. Assistance: If you need assistance for accessibility reasons or if you have any questions, contact Dale Aultman, Secretary to the Farm Credit Administration Board, at (703) 883– 4009. The matters to be considered at the meeting are as follows: A. Closed Session—Risk Management Reports • FCSIC Report on Insurance Risk/ Premium Risk Factors B. Open Session Approval of Minutes • March 12, 2020 C. Quarterly Business Reports • FCSIC Financial Report • Report on Insured Obligations • Report on Annual Performance Plan D. New Business • Mid-Year Review of Insurance Premium Rates Dated: June 15, 2020. Dale Aultman, Secretary, Farm Credit System Insurance Corporation. [FR Doc. 2020–13178 Filed 6–17–20; 8:45 am] BILLING CODE 6705–01–P FEDERAL ELECTION COMMISSION Sunshine Act Meeting Tuesday, June 23, 2020 at 10:00 a.m. and its continuation on June 25, 2020 at 10:00 a.m. TIME AND DATE: 1050 First Street NE, Washington, DC (This meeting will be a virtual meeting). STATUS: This meeting will be closed to the public. MATTERS TO BE CONSIDERED: Compliance matters pursuant to 52 U.S.C. 30109. Matters concerning participation in civil actions or proceedings or arbitration. * * * * * CONTACT PERSON FOR MORE INFORMATION: Judith Ingram, Press Officer; Telephone: (202) 694–1220. PLACE: Vicktoria J. Allen, Acting Deputy Secretary of the Commission. [FR Doc. 2020–13303 Filed 6–16–20; 4:15 pm] BILLING CODE 6715–01–P FEDERAL TRADE COMMISSION Granting of Requests for Early Termination of the Waiting Period Under the Premerger Notification Rules Section 7A of the Clayton Act, 15 U.S.C. 18a, as added by Title II of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, requires persons contemplating certain mergers or acquisitions to give the Federal Trade Commission and the Assistant Attorney General advance notice and to wait designated periods before consummation of such plans. Section 7A(b)(2) of the Act permits the agencies, in individual cases, to terminate this waiting period prior to its expiration and requires that notice of this action be published in the Federal Register. The following transactions were granted early termination—on the dates indicated—of the waiting period provided by law and the premerger notification rules. The listing for each transaction includes the transaction number and the parties to the transaction. The grants were made by the Federal Trade Commission and the Assistant Attorney General for the Antitrust Division of the Department of Justice. Neither agency intends to take any action with respect to these proposed acquisitions during the applicable waiting period. EARLY TERMINATIONS GRANTED MAY 1, 2020 THRU MAY 31, 2020 05/01/2020 20201000 ...... G The Carle Foundation; Advocate Aurora Health, Inc.; The Carle Foundation. 05/04/2020 20200999 ...... 20201001 ...... VerDate Sep<11>2014 G G TPG Partners VIII, L.P.; LifeStance Health, LLC; TPG Partners VIII, L.P. Quincy Health, LLC; Quorum Health Corp.; Quincy Health, LLC. 17:40 Jun 17, 2020 Jkt 250001 PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 36855 E:\FR\FM\18JNN1.SGM 18JNN1

Agencies

ENVIRONMENTAL PROTECTION AGENCY

[Federal Register Volume 85, Number 118 (Thursday, June 18, 2020)]
[Notices]
[Pages 36851-36855]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-13145]


-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OAR-2014-0471; FRL-10010-36-OAR]
RIN 2060-AS26


Granting Petitions To Add 1-bromopropane (Also Known as 1-BP) to 
the List of Hazardous Air Pollutants

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The U.S. Environmental Protection Agency (EPA) is granting 
petitions to add n-propyl bromide (nPB) (Chemical Abstract Service 
(CAS) No. 106-94-5) to the list of hazardous air pollutants (HAP) 
contained in the Clean Air Act (CAA). The EPA is taking final action to 
grant these petitions based on the petitioners having met the 
requirements contained in CAA section 112(b)(3), which allows any 
person to petition the Administrator to add a substance to the list of 
HAP. The term 1-bromopropane (1-BP), which is used throughout this 
document, is the common name for nPB. This is the first occasion on 
which the EPA is granting petitions to add a substance to the list of 
HAP that Congress created in 1990. Following this action, the EPA will 
take a separate regulatory action to add 1-BP to the list of HAP under 
CAA section 112(b)(1).

DATES: The petitions are granted as of June 18, 2020.

ADDRESSES: The EPA has established a docket for this document under 
Docket ID No. EPA-HQ-OAR-2014-0471. All documents in the docket are 
listed on the https://www.regulations.gov/ website. Although listed, 
some information is not publicly available, e.g., Confidential Business 
Information or other information whose disclosure is restricted by 
statute. Certain other material, such as copyrighted material, is not 
placed on the internet and will be publicly available only in hard copy 
form. Publicly available docket materials are available electronically 
through https://www.regulations.gov/. Out of an abundance of caution 
for members of the public and our staff, the EPA Docket Center and 
Reading Room was closed to public visitors on March 31, 2020, to reduce 
the risk of transmitting COVID-19. Our Docket Center staff will 
continue to provide remote customer service via email, phone, and 
webform. There is a temporary suspension of mail delivery to the EPA, 
and no hand deliveries are currently accepted. For further information 
and updates on EPA Docket Center services and the current status, 
please visit us online at https://www.epa.gov/dockets.

FOR FURTHER INFORMATION CONTACT: For questions about this final action, 
contact Mr. John Schaefer, Sector Policies and Programs Division, 
Policies and Strategies Group (D205-02), Office of Air Quality Planning 
and Standards, Environmental Protection Agency, Research Triangle Park, 
North Carolina 27711; telephone number: (919) 541-0296; fax number: 
(919)-541-4991; and email address: [email protected].

SUPPLEMENTARY INFORMATION: 
    Acronyms and abbreviations. We use multiple acronyms and terms in 
this document. While this list may not be exhaustive, to ease the 
reading of this document and for reference purposes, the EPA defines 
the following terms and acronyms here:

1-BP 1-bromopropane (also known as n-propyl bromide (nPB))
CAA Clean Air Act
CAS Chemical Abstract Service
EPA Environmental Protection Agency
HAP hazardous air pollutant(s)
HSIA Halogenated Solvents Industry Alliance
ICL Israel Chemicals Ltd.
MOA mode of action
NESHAP national emission standards for hazardous air pollutants
NTP National Toxicology Program
NYSDEC New York State Department of Environmental Conservation
OMB Office of Management and Budget
PERC perchloroethylene
TRI Toxics Release Inventory

    Organization of this document. The information in this document is 
organized as follows:

I. Background
    A. How do I obtain a copy of this document and other related 
information?
    B. CAA Authority: Petitions to Modify the List of HAP
    C. Petitions Submitted to the EPA
II. What comments were received on the draft document to grant the 
petitions to add 1-BP to the CAA section 112(b)(1) HAP list?
    A. Comments Regarding Estimated 1-BP Emissions
    B. Comments on 1-BP Cancer Risk Factors
    C. Comments Requesting the Addition of 1-BP to the CAA Section 
112(b)(1) HAP List
III. The EPA's Decision to Grant the Petitions
IV. Reducing Emissions from Sources of 1-BP
V. Statutory and Executive Order Review

[[Page 36852]]

    A. Executive Order 12866: Regulatory Planning and Review and 
Executive Order 13563: Improving Regulation and Regulatory Review

I. Background

A. How do I obtain a copy of this document and other related 
information?

    The docket number for this final action is Docket ID No. EPA-HQ-
OAR-2014-0471. In addition to being available in the docket, an 
electronic copy of this document will also be available on the 
internet. The EPA will post a copy of this final action at https://www3.epa.gov/ttn/atw/pollutants/atwsmod.html following official Agency 
signature. Following publication in the Federal Register, the EPA will 
post the Federal Register version and key technical documents on this 
same website.

B. CAA Authority: Petitions To Modify the List of HAP

    The CAA section 112(b)(3)(A) specifies that any person may petition 
the Administrator to modify the list of HAP contained in CAA section 
112(b)(1) by adding or deleting a substance. CAA section 112(b)(3)(B) 
sets out the substantive criteria for granting a petition. It calls for 
the Administrator to add a substance to the CAA section 112(b)(1) list, 
otherwise known as the HAP list, ``upon a showing by the petitioner or 
on the Administrator's own determination that the substance is an air 
pollutant and that emissions, ambient concentrations, bioaccumulation 
or deposition of the substance are known to cause or may reasonably be 
anticipated to cause adverse effects to human health or adverse 
environmental effects.'' The Administrator is required under the CAA 
section 112(b)(3)(A) to either grant or deny a petition within 18 
months of the receipt of a complete petition by publishing a written 
explanation of the reasons for the Administrator's decision. The 
Administrator may not deny a petition based solely on inadequate 
resources or time for review.
    Finally, under the CAA section 112(e)(4), the Administrator's 
decision to add a pollutant to the CAA section 112(b)(1) HAP list is 
not a final Agency action subject to judicial review, except that any 
such action may be reviewed when the Administrator promulgates emission 
standards for the pollutant. Accordingly, this decision to grant 
petitions to add 1-BP to the HAP list is not subject to judicial review 
until the Administrator promulgates applicable the CAA section 112(d) 
standards addressing emissions of 1-BP. Under the CAA section 112(d) 
the EPA has a ``clear statutory obligation to set emissions standards 
for each listed HAP.'' National Lime Association v. EPA, 233 F. 3d 625, 
634 (D.C. Cir. 2000). Additionally, under CAA section 112(c)(5), the 
EPA is required to promulgate emission standards under the CAA sections 
112(d)(2) and (3) within two years of adding a new source category to 
the CAA section 112(c)(1) source category list.
    This is the first occasion on which the EPA is granting a petition 
to add a substance to the list of HAP that Congress created in 1990. 
Since 1990, the EPA has amended the CAA section 112(b)(1) HAP list by 
removing four listed HAPs. They are caprolactam (61 FR 30816 (June 18, 
1996)); ethylene glycol monobutyl ether (69 FR 69320 (August 2, 2000)); 
surfactant alcohol ethoxylates and their derivatives (these are 
compounds that were considered to be included in glycol ethers, which 
is a listed HAP; (65 FR 47342 (August 2, 2000)); and methyl ethyl 
ketone (MEK) (70 FR 75047 (December 19, 2005)). For more information, 
see https://www.epa.gov/haps/initial-list-hazardous-air-pollutants-modifications#mods. The EPA has also denied a petition to remove 
methanol from the CAA section 112(b)(1) HAP list. 66 FR 21929 (May 2, 
2001).

C. Petitions Submitted to the EPA

    Halogenated Solvents Industry Alliance (HSIA) and New York State 
Department of Environmental Conservation (NYSDEC) submitted petitions 
to add 1-BP to the CAA section 112(b)(1) HAP list on October 28, 2010, 
and November 24, 2011, respectively. Both HSIA and NYSDEC petitions 
referred to the chemical as nPB and 1-BP. In an action published on 
November 23, 2015, the EPA added the chemical by the name 1-BP to the 
Community Right-to-Know Toxic Chemical Release Reporting requirements. 
In addition, the chemical is listed in the EPA's Substance Registry 
Services, the EPA's authoritative resource for basic information about 
chemicals, as 1-BP. Finally, the chemical is currently undergoing an 
EPA Toxic Substances Control Act risk evaluation, under Docket ID No. 
EPA-HQ-OPPT-2015-0084 as 1-BP. Therefore, for this action and for 
future regulations under the CAA, the EPA will refer to the chemical 
identified by CAS No. 106-94-5 as 1-bromopropane or 1-BP.
    On November 28, 2012, in response to the EPA's requests for 
additional data, HSIA supplemented its petition. Following the receipt 
of the petitions, the EPA conducted a review to determine whether the 
petitions were complete according to Agency criteria for the CAA 
section 112(b) actions, which we explained in the February 6, 2015, 
document (80 FR 6676). Specifically, after reviewing these petitions 
and supplemental information, the EPA determined that the petitions 
addressed all the necessary subject areas for the Agency to assess 
whether emissions, ambient concentrations, bioaccumulation, or 
deposition of 1-BP are known to cause or may reasonably be anticipated 
to cause adverse human health effects or adverse environmental effects. 
The EPA determined these petitions to add 1-BP to the HAP list to be 
complete and published a notification of receipt of a complete petition 
in the Federal Register on February 6, 2015 (80 FR 6676), and invited 
the public to comment on the technical merits of these petitions and to 
submit any information relevant to the technical review of the 
petitions. On March 11, 2015 (80 FR 12794), the EPA agreed to extend 
the comment period for the notification of receipt of complete 
petitions to May 7, 2015.
    On January 9, 2017, the EPA published a draft document in the 
Federal Register containing the Agency's intended rationale for 
granting the petitions to add 1-BP to the CAA section 112(b)(1) HAP 
list (82 FR 2354). In the draft document, the EPA determined that these 
petitions met criteria specified in the CAA section 112(b): i.e., 1-BP 
is an air pollutant and its emissions and ambient concentrations ``may 
reasonably be anticipated to cause adverse effects to human health.'' 
Subsequently, on June 6, 2017, the EPA published an action granting the 
request by Albemarle Corporation, a U.S.-based manufacturer of 1-BP, to 
extend the comment period until October 1, 2017, to provide an 
opportunity for prospective commenters to review the 2017 Toxics 
Release Inventory (TRI), which included newly required emission 
reporting of 1-BP (82 FR 26091). This current action is the final step 
in granting the petitioners' request to add 1-BP to the CAA section 
112(b)(1) HAP list. Even following the granting of this petition to add 
1-BP to the list, sources will remain under no regulatory or statutory 
obligation to reduce emissions of 1-BP until a separate regulatory 
action is taken. In section IV of this document, we explain the future 
additional regulatory actions that the EPA intends to consider either 
simultaneously with the addition of 1-BP to the CAA section 112(b)(1) 
HAP list or soon thereafter.

[[Page 36853]]

II. What comments were received on the draft document to grant the 
petitions to add 1-BP to the CAA section 112(b)(1) HAP list?

    The EPA received 12 comments on the draft document to add 1-BP to 
the CAA section 112(b)(1) list of HAP. Two commenters opposed adding 1-
BP to the CAA section 112(b)(1) HAP list, while 10 commenters supported 
the action. All comments are in the docket for this action. A summary 
of the major comments and our responses are presented in this section.

A. Comments Regarding Estimated

1-BP Emissions

    Comment: Albemarle Corporation requested that the EPA extend the 
comment period to October 1, 2017, to ensure that data from the TRI 
database for 1-BP would inform the final document. Albemarle 
Corporation stated the extension would provide the public with an 
opportunity to review the TRI dataset for 1-BP usage, sources, and 
emissions and also to use those data to prepare meaningful comments on 
the draft document.
    Response: The EPA also agreed that it would be useful to review 
reported TRI emissions releases for 1-BP prior to finalizing the 
document. Since January 2017, when the draft document was published, 
two years of emissions data had been submitted to the EPA's TRI. 
Specifically, one commenter provided TRI data for 1-BP for calendar 
year 2016 during the extended comment period. Further, according to the 
EPA's TRI, in 2016, 55 facilities (in 27 states) reported emissions 
totaling 626,659 pounds (more than 313 tons) of 1-BP into the air, with 
multiple sources reporting emissions in excess of 20,000 pounds (10 
tons per year). Total 1-BP air emissions reported to TRI in 2017 were 
746,562 pounds (more than 373 tons).
    Finally, the emissions data provided supported the risk analysis 
submitted by HSIA. The primary risk driver for the analysis was a 
degreasing operation in Collegeville, Pennsylvania, where the maximum 
individual lifetime risk was estimated at 38-in-1 million. The 
emissions reported by the facility to the TRI database showed 
approximately 70 tons per year of 1-BP emissions, which supports the 
petitioner's emissions estimates and the assertion that 1-BP may 
present a risk to human health.
    Comment: Albemarle Corporation also commented that the emission 
estimates used by petitioners to estimate the fenceline ambient 
concentration of 1-BP lacked accuracy and were ``wholly inadequate to 
support the petition.'' They requested an extension of the comment 
period to October 1, 2017, in order to resolve the significant 
differences between the estimates provided by the petitioner, HSIA, and 
the commenter's estimated emissions.
    Response: The EPA agreed that resolving any differences between the 
commenter's emission estimates and the petitioner's estimates was an 
important issue that needed to be resolved prior to deciding on the 
petitions. Therefore, the EPA extended the comment period until October 
1, 2017 (82 FR 26091, June 6, 2017). The commenter, however, did not 
provide additional information during the comment period extension. The 
EPA evaluated HSIA's emission estimates and modeling assumptions and 
found them to be reasonable and found their risk assessment methodology 
consistent with the best practices for estimating carcinogenic risk for 
an air pathway analysis. Given that no evidence was provided to change 
the EPA's previous review of the petitioner's risk assessment, the 
petitioner's original emission estimates used for the air pathway risk 
modeling were found to be acceptable and to provide the basis for a 
reasonable analysis of the risks associated with inhalation of 1-BP.

B. Comments on 1-BP Cancer Risk Factors

    Comment: Israel Chemicals Ltd. (ICL) requested that the EPA 
reconsider its initial decision to add 1-BP to the HAP list. ICL made 
this request based on a September 2016 study titled In Vivo Mutation 
Assay of n-Propyl Bromide at the cII Locus in Big Blue[supreg] 
Transgenic B6C3F1 Mice Exposed via Whole-Body Inhalation.\1\ Based on 
this study, ICL argued for removing cancer as a potential hazard from 
1-BP exposure, which, in their view, would eliminate the basis for 
listing 1-BP as a HAP.
---------------------------------------------------------------------------

    \1\ https://www.regulations.gov/, Docket ID Item No. EPA-HQ-OAR-
2014-0471-0067.
---------------------------------------------------------------------------

    Response: The EPA rejects the premise that the results of a single 
assay for mutagenicity in a single gene locus in a transgenic (Big 
Blue[supreg]) mouse strain can be used to make general statements on 
potential mutagenicity or carcinogenicity. The EPA finds adequate 
support from submitted evidence and comments that 1-BP presents a 
potential cancer hazard and, therefore, is granting these petitions to 
list 1-BP as a HAP for purposes of regulatory actions based on the 
following considerations:
    First, not all carcinogens operate via a mutagenic mode of action 
(MOA). In fact, many of the National Toxicology Program (NTP) 
substances categorized as ``Known to be a human carcinogen'' are 
carcinogenic via non-mutagenic mechanisms. There is mixed evidence of 
mutations in bacterial and mammalian cells and limited data on DNA 
damage in 1-BP-exposed workers. However, there is clear evidence for 
the carcinogenicity of 1-BP in multiple tissues in two rodent species 
from a 2-year cancer bioassay \2\ by the NTP. The NTP's Report on 
Carcinogens, 14th Edition \3\ finds 1-BP is ``reasonably anticipated to 
be a human carcinogen'' based on sufficient evidence of carcinogenicity 
from studies in experimental animals.
---------------------------------------------------------------------------

    \2\ https://ntp.niehs.nih.gov/testing/status/agents/ts-m000017.html.
    \3\ https://ntp.niehs.nih.gov/ntp/roc/content/profiles/bromopropane.pdf.
---------------------------------------------------------------------------

    Second, regarding the ICL claim that if 1-BP is not a mutagen, any 
cancer potential will be a threshold effect. The 2005 EPA Cancer 
Guidelines \4\ provide the latitude to apply a non-linear model when 
data positively establish the MOA to be non-linear. However, it is not 
automatically assumed that a non-linear MOA is operational if a 
chemical is not a mutagen.
---------------------------------------------------------------------------

    \4\ https://www.epa.gov/sites/production/files/2013-09/documents/cancer_guidelines_final_3-25-05.pdf.
---------------------------------------------------------------------------

    Third, as explained in greater detail in the draft document, there 
is significant evidence that 1-BP poses a negative health impact for 
noncancer effects including reproductive toxicity and neurotoxicity in 
both controlled and uncontrolled environments; the evidence for these 
noncancer effects provides sufficient justification to list 1-BP as a 
HAP, regardless of the potential for a cancer effect (82 FR 2354, 2360-
61, January 9, 2017).
    Finally, as also explained in the draft document, the EPA 
``interpret[s] the CAA section 112(b)(3)(B) as invoking the 
Administrator's expertise in considering information/data that 
addresses the potential or likelihood of harm rather than concrete 
proof of actual harm,'' and that the Administrator is authorized to 
``act in the face of uncertainty as to the proven health effects of a 
substance'' and to ``draw inferences from the data'' before him. (82 FR 
2357, January 9, 2017); see generally Id. at 2356-58, 2361-62.

C. Comments Requesting the Addition of 1-BP to the CAA Section 
112(b)(1) HAP List

    Comment: Ten commenters supported the EPA's initial decision to 
grant petitions to add 1-BP to the CAA section 112(b)(1) HAP list and 
encouraged the EPA to issue a final action granting the petitions. They 
also

[[Page 36854]]

stated that petitioners had provided substantial evidence to support 
the conclusion that 1-BP either is known to cause or can reasonably be 
anticipated to cause cancer and noncancer health effects in humans. 
Their comments generally discussed this evidence.
    One commenter stated that the decision to list 1-BP as a HAP under 
the CAA depends only on showing potential adverse effects from a 
chemical, not whether exposure is at levels that cause those effects. 
The commenter also noted that exposures of concern for 1-BP are already 
occurring. The commenter likewise disagreed with the negative 
mutagenesis assay findings submitted by ICL, stating that results of a 
single assay for mutagenicity cannot be used to apply across-the-board 
statements on potential mutagenicity.
    Response: The EPA acknowledges commenters' statements. The EPA also 
agrees with the comments on the availability of substantial evidence to 
support the addition of 1-BP to the CAA section 112(b)(1) HAP list.

III. The EPA's Decision To Grant the Petitions

    Consistent with the draft document, petitioners have provided 
sufficient information demonstrating the adverse health effects of 1-BP 
that supports the EPA's determination that 1-BP is an air pollutant as 
defined under the CAA section 302(g) and that ``emissions, ambient 
concentrations, bioaccumulation or deposition of the substance are 
known to cause or may reasonably be anticipated to cause adverse 
effects to human health or adverse environmental effects'' as specified 
under CAA section 112(b)(3)(B). The documented known or anticipated 
adverse health effects of 1-BP, which are based on established sound 
scientific principles, include carcinogenicity, reproductive toxicity, 
and neurotoxicity. The EPA also concludes that petitioners' assessments 
regarding estimates of potential ambient concentrations of 1-BP that 
are likely to result at a facility's fenceline, process emissions 
related information, and chemical usage information that are 
representative of normal operating conditions are reasonable. The EPA 
is, therefore, granting petitions to add 1-BP to the CAA section 
112(b)(1) list of HAP. This action concludes the petition process under 
the CAA section 112(b)(3). As previously explained, the EPA's granting 
of the petitions by itself, as accomplished by this document, does not 
impose any regulatory or statutory obligations on sources of 1-BP 
emissions. Following this action, the EPA will take a separate 
regulatory action to add 1-BP to the list of HAP under the CAA section 
112(b)(1). At that time, the EPA will publish a Federal Register 
document that formally proposes the addition of 1-BP to the CAA section 
112(b)(1) HAP list and assess the impacts of adding 1-BP to the HAP 
list on potentially affected sources.

IV. Reducing Emissions From Sources of 1-BP

    The first step in this process is to grant the petitions requesting 
that 1-BP be listed as a HAP, which we are completing with this action. 
As a general matter, granting a petition to add an air pollutant to the 
CAA section 112(b)(1) HAP list initiates the process of bringing the 
air pollutant into consideration in the national emission standards for 
hazardous air pollutants (NESHAP) program, under the CAA section 
112(d). (The CAA section 112(d) imposes a ``clear statutory obligation 
to set emissions standards for each listed HAP.'' National Lime 
Association v. EPA, 233 F. 3d 625, 634 (D.C. Cir. 2000)). As previously 
explained, by itself, granting the petitions will not create new 
regulatory or statutory obligations for sources that emit 1-BP, until 
further actions are taken by the Agency. During the period from when 
this document is published and until the next step of adding 1-BP to 
the CAA section 112(b)(1) HAP list is taken, sources emitting 1-BP will 
have no regulatory obligations related to approval of the petitions.
    The second step is to publish a Federal Register document that 
formally announces the addition of 1-BP to the CAA section 112(b)(1) 
HAP list. In granting the petitions to list 1-BP as a HAP, the EPA has 
learned that most source categories emitting 1-BP will not become 
subject to emission standards until the EPA amends or promulgates new 
maximum achievable control technology standards for specific source 
categories. The single largest user of 1-BP is the Halogenated Solvent 
Cleaning source category. However, the current Halogenated Solvent 
Cleaning NESHAP (40 CFR part 63, subpart T) does not regulate 1-BP 
emissions because only emissions of methylene chloride, 
perchloroethylene (PERC), and trichloroethylene (TCE) are subject to 
the rule. Therefore, the use of 1-BP as a solvent degreaser will not be 
subject to regulation until such time as the EPA revises 40 CFR part 
63, subpart T, issues new standards, or takes other actions to reduce 
1-BP emissions from the Halogenated Solvent Cleaning source category.
    Further, the EPA may need to take additional regulatory action to 
address 1-BP emissions from certain dry cleaning operations. The PERC 
Dry Cleaning source category, which sets out requirements for these 
operations, covers only PERC emissions. PERC is a solvent used in dry 
cleaning and has been identified as a probable human carcinogen. 40 CFR 
63.322(o)(5)(i) requires that the existing co-residential dry cleaning 
subcategory phase out the use of PERC by December 21, 2020. The EPA has 
learned that 1-BP is currently used as a replacement solvent in this 
subcategory. Considering the public health effects discussed earlier in 
this document and the information before us, the EPA is concerned about 
the use of 1-BP as a substitute for PERC in the co-residential dry 
cleaning subcategory. Further, these public health effects may call for 
the need for adequate controls for 1-BP emissions from other dry 
cleaning subcategories other than the dry cleaning co-residential 
subcategory. The EPA is, therefore, planning in a future action to 
modify the CAA section 112(c)(1) source category list to add a new 
source category that would cover 1-BP emissions from all dry cleaning 
operations. Under the CAA section 112(c)(5), the EPA may add additional 
source categories to the CAA section 112(c)(1) source category list.
    Beyond the Halogenated Solvent Cleaning source category and 1-BP 
dry cleaning operations, the EPA does not believe that other source 
categories need to be added to the source category list or otherwise 
modified to reduce emissions of 1-BP. After adding a new source 
category to regulate 1-BP emissions from dry cleaning operations, the 
EPA would be required under CAA section 112(c)(5), to promulgate 
emission standards under the CAA section 112(d) within two years.
    Additionally, some sources could become immediately subject to 
existing standards once 1-BP is placed on the CAA section 112(b)(1) 
list given that these sources may become major sources of HAP emissions 
(greater than 10 tons per year of a single HAP or 25 tons per year of 
total HAP). For these sources, 40 CFR 63.6(c)(5) allows three years to 
comply after 1-BP is added to the HAP list unless the underlying rule 
specifies another schedule.
    These future actions that the EPA intends to consider for purposes 
of addressing 1-BP emissions reduction, such as the listing of new 
source categories under the CAA section 112(c)(1), can occur either 
simultaneously with listing 1-BP on the HAP list or shortly thereafter. 
In sum, as a result of granting these petitions, the EPA intends to 
consider taking additional regulatory actions as a result

[[Page 36855]]

of adding 1-BP to the CAA section 112(b)(1) HAP list.

V. Statutory and Executive Order Review

    Additional information about this Executive Order can be found at 
https://www.epa.gov/laws-regulations/laws-and-executive-orders.

A. Executive Order 12866: Regulatory Planning and Review and Executive 
Order 13563: Improving Regulation and Regulatory Review

    This action is a significant regulatory action that was submitted 
to the Office of Management and Budget (OMB) for review because it 
raises novel legal or policy issues. Any changes made in response to 
OMB recommendations have been documented in the docket.

Andrew Wheeler,
Administrator.
[FR Doc. 2020-13145 Filed 6-17-20; 8:45 am]
BILLING CODE 6560-50-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.